These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23100242)

  • 61. Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series.
    Ceccarelli SM; Schlotterbeck G; Boissin P; Binder M; Buettelmann B; Hanlon S; Jaeschke G; Kolczewski S; Kupfer E; Peters JU; Porter RH; Prinssen EP; Rueher M; Ruf I; Spooren W; Stämpfli A; Vieira E
    ChemMedChem; 2008 Jan; 3(1):136-44. PubMed ID: 17994660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes.
    Kuuranne T; Leinonen A; Schänzer W; Kamber M; Kostiainen R; Thevis M
    Drug Metab Dispos; 2008 Mar; 36(3):571-81. PubMed ID: 18086831
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug testing.
    Cowan DA
    Essays Biochem; 2008; 44():139-48. PubMed ID: 18384288
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of mepitiostane metabolites in human urine by liquid chromatography/tandem mass spectrometry for sports drug testing.
    Okano M; Sato M; Kojima A; Kageyama S
    J Pharm Biomed Anal; 2015 Nov; 115():236-44. PubMed ID: 26247800
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
    Thevis M; Schänzer W
    J Pharm Biomed Anal; 2014 Dec; 101():66-83. PubMed ID: 24906629
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing.
    Guddat S; Fußhöller G; Beuck S; Thomas A; Geyer H; Rydevik A; Bondesson U; Hedeland M; Lagojda A; Schänzer W; Thevis M
    Anal Bioanal Chem; 2013 Oct; 405(25):8285-94. PubMed ID: 23877183
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sports doping: emerging designer and therapeutic β2-agonists.
    Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
    Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing.
    Dib J; Schlörer N; Schänzer W; Thevis M
    J Mass Spectrom; 2015 Feb; 50(2):407-17. PubMed ID: 25800023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 6alpha-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control.
    Parr MK; Kazlauskas R; Schlörer N; Opfermann G; Piper T; Schulze G; Schänzer W
    Rapid Commun Mass Spectrom; 2008; 22(3):321-9. PubMed ID: 18181236
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis.
    Thevis M; Sigmund G; Thomas A; Vogel M; Walpurgis K; Kwiatkowska D; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2014 Apr; 28(7):781-6. PubMed ID: 24573809
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
    Thomas A; Solymos E; Schänzer W; Baume N; Saugy M; Dellanna F; Thevis M
    Anal Chim Acta; 2011 Nov; 707(1-2):107-13. PubMed ID: 22027126
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Schiffer AK; Schänzer W
    Eur J Mass Spectrom (Chichester); 2006; 12(2):129-36. PubMed ID: 16723754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
    Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
    J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis.
    Thevis M; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2005; 19(7):928-36. PubMed ID: 15747323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Applications and progresses of liquid chromatography-mass spectrometry in doping control].
    Qin Y; Xu Y; Yang S; Zhu S
    Se Pu; 2008 Jul; 26(4):431-6. PubMed ID: 18959237
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
    Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.